Cleared Traditional

K200287 - BP-BT Kiosk

K200287 is the FDA 510(k) clearance for BP-BT Kiosk by Ld Technology, LLC. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 100-day FDA review.

K200287 · Ld Technology, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2020
Decision
100d
Days
Class 2
Risk

K200287 is an FDA 510(k) clearance for the BP-BT Kiosk. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Ld Technology, LLC (Miami, US). The FDA issued a Cleared decision on May 15, 2020 after a review of 100 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Ld Technology, LLC devices

Submission Details

510(k) Number K200287 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 05, 2020
Decision Date May 15, 2020
Days to Decision 100 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 125d · This submission: 100d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 500
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K200287.
Full Automatic(NIBP) Blood Pressure Monitor
K200521 · Health & Life Co., Ltd. · Jun 2020
Automatic Digital Blood Pressure Monitor
K190982 · Xiamen Ants Bro Technology Co., Ltd. · May 2020
Medtronic Commander Flex
K191745 · Medtronic Care Management Services · May 2020
Globalcare Blood Pressure Monitor
K192609 · Globalcare Medical Technology Co., Ltd. · Apr 2020
Upper Arm Blood Pressure Monitor
K191894 · Shenzhen Zhengkang Technology Co., Ltd. · Feb 2020
Seca Medical Vital Signs Analyzer 535, Seca mVSA 535, Seca mVSA, Seca 535
K192092 · Seca GmbH & Co. KG · Jan 2020